An open-label, multi-center, patient handling study of mometasone furoate/formoterol fumarate [mometasone/formoterol] MDI [metered dose inhaler] with an integrated dose counter in adolescent and adult subjects and adult with asthma or COPD [chronic obstructive pulmonary disease]

Trial Profile

An open-label, multi-center, patient handling study of mometasone furoate/formoterol fumarate [mometasone/formoterol] MDI [metered dose inhaler] with an integrated dose counter in adolescent and adult subjects and adult with asthma or COPD [chronic obstructive pulmonary disease]

Completed
Phase of Trial: Phase III

Latest Information Update: 18 Apr 2017

At a glance

  • Drugs Mometasone/formoterol (Primary)
  • Indications Asthma; Chronic obstructive pulmonary disease
  • Focus Therapeutic Use
  • Sponsors Schering-Plough
  • Most Recent Events

    • 29 Jan 2009 Actual initiation date changed from Feb 2008 to Mar 2008 as reported by ClinicalTrials.gov.
    • 29 Jan 2009 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
    • 24 Dec 2008 Status changed from recruiting to active, no longer recruiting, reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top